Back to Search Start Over

[Urogenital chlamydia infection: treatment with wilprafen].

Authors :
Iakubovich AI
Chuprin AE
Rakitin DA
Source :
Urologiia (Moscow, Russia : 1999) [Urologiia] 2003 Jan-Feb (1), pp. 55-8.
Publication Year :
2003

Abstract

Antibiotic wilprafen (josamycin) was given in a dose 500 mg per os two times a day for 15 days to 30 male patients with a long history of chronic Chlamydia trachomatis infection (CTI) treated ineffectively. The control examination has not detected Chlamydia in 29 (96.5%) patients. The results demonstrate high efficacy of the drug wilprafen in the treatment of patients with urogenital CTI.

Subjects

Subjects :
Administration, Oral
Adult
Age Factors
Anti-Bacterial Agents administration & dosage
Follow-Up Studies
Humans
Josamycin administration & dosage
Josamycin therapeutic use
Male
Middle Aged
Sex Factors
Time Factors
Anti-Bacterial Agents therapeutic use
Chlamydia Infections drug therapy
Chlamydia trachomatis
Male Urogenital Diseases drug therapy

Details

Language :
Russian
ISSN :
1728-2985
Issue :
1
Database :
MEDLINE
Journal :
Urologiia (Moscow, Russia : 1999)
Publication Type :
Academic Journal
Accession number :
12621971

Tools

Authors Abstract Subjects Details